Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
Abstract Lipopolysaccharide (LPS) as an important inflammatory mediator activates the innate/adaptive immune system. The existence of LPS in pancreatic ductal adenocarcinoma (PDAC) has been reported, however, its biological function in PDAC remains unclear. Here, we demonstrated that circulating and...
Main Authors: | Hanlin Yin, Ning Pu, Qiangda Chen, Jicheng Zhang, Guochao Zhao, Xuefeng Xu, Dansong Wang, Tiantao Kuang, Dayong Jin, Wenhui Lou, Wenchuan Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-10-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04293-4 |
Similar Items
-
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
by: Junbin Chen, et al.
Published: (2020-06-01) -
Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis
by: Chao Zheng, et al.
Published: (2020-01-01) -
CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer
by: Ning Pu, et al.
Published: (2018-10-01) -
Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88
by: Jiro Sakai, et al.
Published: (2017-05-01) -
Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw.
by: Igor L Calil, et al.
Published: (2014-01-01)